Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:828-834
Published online before print February 2, 2009, doi: 10.1161/CIRCULATIONAHA.108.799403
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/6/828    most recent
CIRCULATIONAHA.108.799403v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Werkum, J. W.
Right arrow Articles by ten Berg, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Werkum, J. W.
Right arrow Articles by ten Berg, J. M.
Related Collections
Right arrow Risk Factors
Right arrow Arterial thrombosis
Right arrow Thrombosis risk factors
Right arrow Catheter-based coronary interventions: stents
Right arrowRelated Article

(Circulation. 2009;119:828-834.)
© 2009 American Heart Association, Inc.


Interventional Cardiology

Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis

An Analysis of 431 Cases

Jochem W. van Werkum, MD, PhD; Antonius A.C.M. Heestermans, MD; Fleur I. de Korte, MD; Johannes C. Kelder, MD; Maarten-Jan Suttorp, MD, PhD; Benno J.W.M. Rensing, MD, PhD; Bastiaan Zwart, MSc, PhD; B. R. Guus Brueren, MD, PhD; Jacques J. Koolen, MD, PhD; Jan-Henk E. Dambrink, MD, PhD; Arnoud W.J. van't Hof, MD, PhD; Freek W.A. Verheugt, MD, PhD; Jurriën M. ten Berg, MD, PhD

From the Department of Cardiology, St. Antonius Hospital (J.W.v.W., F.I.d.K., J.C.K., M.-J.S., B.J.W.M.R., B.Z., J.M.t.B.), Nieuwegein, Netherlands; the Department of Cardiology, Isala Klinieken (A.A.C.M.H., J.-H.E.D., A.W.J.v.H.), Zwolle, Netherlands; the Department of Cardiology, Catharina Hospital (B.R.G.B., J.J.K.), Eindhoven, Netherlands; and the Department of Cardiology, UMC St. Radboud (J.W.v.W., F.W.A.V.), Nijmegen, Netherlands.

Reprint requests to J.M. ten Berg, MD, PhD, FACC, Department of Cardiology, St. Antonius Hospital, PO Box 2500, 3435 CM Nieuwegein, Netherlands. E-mail berg03{at}antonius.net

Received June 16, 2008; accepted November 30, 2008.

Background— There are limited data on the long-term clinical outcome after an angiographically confirmed (definite) stent thrombosis (ST).

Methods and Results— Four hundred thirty-one consecutive patients with a definite ST were enrolled in this multicenter registry. The primary end point was the composite of cardiac death and definite recurrent ST. Secondary end points were all-cause death, cardiac death, definite recurrent ST, definite and probable recurrent ST, any myocardial infarction, and any target-vessel revascularization. The primary end point occurred in 111 patients after a median follow-up of 27.1 months. The estimated cumulative event rates at 30 days and 1, 2, and 3 years were 18.0%, 23.6%, 25.2%, and 27.9%, respectively. The cumulative incidence rates of definite recurrent ST, definite or probable recurrent ST, any myocardial infarction, and any target-vessel revascularization were 18.8%, 20.1%, 21.3%, and 32.0%, respectively, at the longest available follow-up. Independent predictors for the primary end point were diabetes mellitus, total stent length, severe calcification, American College of Cardiology/American Heart Association B2-C lesions, TIMI (Thrombolysis In Myocardial Infarction) flow grade <3 after percutaneous coronary intervention, and left ventricular ejection fraction <45%. The implantation of an additional coronary stent during the first ST was also associated with unfavorable outcome. Clinical outcome was not affected by the type of previously implanted stent (drug-eluting or bare-metal stent) or the category of ST (early versus late).

Conclusions— The long-term clinical outcome after a first definite ST is unfavorable, with a high mortality and recurrence rate. Diabetes mellitus, left ventricular ejection fraction <45%, long total stent length, complex coronary lesions, TIMI flow grade <3 after percutaneous coronary intervention, and implantation of an additional coronary stent during the emergent percutaneous coronary intervention for the ST were associated with this unfavorable outcome.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 119: 765-767. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. C. Becker, J. Scheiman, H. L. Dauerman, F. Spencer, S. Rao, M. Sabatine, D. A. Johnson, F. Chan, N. S. Abraham, E. M.M. Quigley, et al.
Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures
J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2261 - 2276.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. P. Giugliano and E. Braunwald
The Year in Non-ST-Segment Elevation Acute Coronary Syndrome.
J. Am. Coll. Cardiol., October 13, 2009; 54(16): 1544 - 1555.
[Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
D. Adlam, R. Ayers, and K. M. Channon
Intimal Dissection Causing Late Thrombosis of a Covered Stent: Optical Coherence Tomography Appearances
Circ Cardiovasc Interv, August 1, 2009; 2(4): 359 - 360.
[Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
J. M. Lasala, D. A. Cox, D. Dobies, K. Baran, W. B. Bachinsky, E. W. Rogers, J. A. Breall, D. H. Lewis, A. Song, R. M. Starzyk, et al.
Drug-Eluting Stent Thrombosis in Routine Clinical Practice: Two-Year Outcomes and Predictors From the TAXUS ARRIVE Registries
Circ Cardiovasc Interv, August 1, 2009; 2(4): 285 - 293.
[Abstract] [Full Text] [PDF]